MDC Translational Science and Clinical Research Grants Competition Opens for 2024-25
Muscular Dystrophy Canada’s annual Neuromuscular Research Grant Program is now open for 2024-25!
The annual Neuromuscular Research Grant Program invests in projects related to the diagnosis, treatment, or clinical care of neuromuscular disorders. These grants are intended to: fill gaps in the existing funding landscape; enable researchers to build new and innovative research; support proof-of-concept, feasibility and pilot studies in preparation for larger-scale, longer-term grants from external sources. MDC grants also facilitate partnerships between researchers and patients.
Two streams are available: Translational Science Grants and Clinical Research Grants
- Application Open: September 3, 2024
- Application Deadline: November 18, 2024 at 11:59 pm (ET)
- Notice of Decision: March 3, 2025
- Funding Start Date: April 1, 2025
MDC welcome research grants focused on one or multiple neuromuscular disorders (NMD). In this cycle, we especially encourage proposals focusing on Friedreich ataxia, Charcot-Marie-Tooth disease / hereditary motor and sensory neuropathies (HMSN), myotonic dystrophy, limb-girdle muscular dystrophy and collagen VI-related dystrophy.
Visit the MDC Translational Science and Clinical Research Grants webpage to learn more, or view the funding application guidelines here. For further inquiries, please contact Dr. Homira Osman, VP of Research and Public Policy, Muscular Dystrophy Canada at <>.
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.